Skip to main content

Day: May 19, 2020

Vistin Pharma ASA: Minutes from the Annual General Meeting 2020

Oslo, Norway, 19 May 2020Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the Annual General Meeting held on 19 May 2020. All matters were resolved as proposed in the call for the annual general meeting.For further information, please contact:Alexander KarlsenCFO+47 97 05 36 21alexander.karlsen@vistin.comThis information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. AttachmentMinutes from AGM 2020 Vistin Pharma ASA

Continue reading

North Bud Farms Announces Proposed Terms for Non-Brokered Private Placement of Units

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.TORONTO, May 19, 2020 (GLOBE NEWSWIRE) — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce that it intends to complete a non-brokered private placement of units (each a “Unit”) at a price of $0.05 per Unit for gross proceeds of up to C$2 million, subject to the Company’s receipt of minimum gross proceeds of C1$ million (the “Offering”).Each Unit will be comprised of one common share in the capital of the Company (a “Common Share”) and one common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder thereof to acquire one Common Share (a “Warrant Share”) for a period...

Continue reading

The Movie Studio Utilizes Digital Marketplace Platform for Global Licensing, Distribution of Motion Picture Content

FORT LAUDERDALE, Fla., May 19, 2020 (GLOBE NEWSWIRE) — via NetworkWire – The Movie Studio, Inc. (OTC: MVES) (the “Company”) today announces its integration with a digital content platform that brings sellers and distributors into one online digital marketplace. The platform enables The Movie Studio to showcase its motion picture content, title discovery of feature films to a trusted global community of buyers, and creates the opportunity to monetize the use of its movies and content.The utilization of blockchain technology regarding digital content ingestion and distribution mechanisms  is revolutionizing the content availability for worldwide marketing and licensing.The platform brings together content distributors, buyers and creators, utilizing smart contracts and digital intelligence with 24-hour access to the platform,...

Continue reading

Veritas Farms Launches Hand Sanitizer Product on E-Commerce Website

Fort Lauderdale, FL, May 19, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Veritas Farms, Inc. (OTCQB: VFRM), a vertically-integrated agribusiness focused on the production of full spectrum hemp extracts with naturally occurring cannabinoids, is pleased to announce that its newly launched Veritas Farms™ hand sanitizer product is now available for sale on the Company’s e-commerce website.The hand sanitizer, which contains 70% isopropyl alcohol, aloe vera and vitamin E, is now available for sale and shipment nationwide through Veritas Farms’ robust online platform at https://www.theveritasfarms.com/shop/Veritas Farms™ hand sanitizer is packaged in an 8-ounce squeeze bottle and was developed in partnership with and produced locally by The Miami Distilling Company, a subsidiary of Toast Distillers, Inc.Alexander M. Salgado, CEO and...

Continue reading

Kalytera Announces Binding Agreement to Acquire Salzman Group

SAN FRANCISCO, May 19, 2020 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera“) announced today that it has signed a binding Letter of Intent dated May 12, 2020 (the “LOI”) to acquire Salzman Group, Inc., a privately held company located in West Tisbury, MA (“Salzman Group”). Salzman Group is the owner of R-107, a proprietary drug with issued and pending composition of matter and method of use patents in approximately 40 countries, including the U.S., Australia, Brazil, China, Europe, India, Japan, Russia and South Korea. Salzman Group is developing R-107 for treatment of COVID-19 associated lung disease, chlorine inhalation lung injury (“CILI”) and pulmonary arterial hypertension (“PAH”). Subject to completion of customary due diligence, the Company...

Continue reading

CEMATRIX Corporation Announces $3.0M in Contracts and Increases Total Backlog to $80.4M CDN

CALGARY, Alberta, May 19, 2020 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (the “Corporation” or “CEMATRIX”) a North American leading manufacturer and supplier of technologically advanced cellular concrete products today announced that its wholly owned operating subsidiaries, CEMATRIX (Canada) Inc. (“CCI”), MixOnSite USA Inc. (“MOS”) and Pacific International Grout Company (“PIGCO”) have contracted several new infrastructure projects with a total contract value of $3.0M CDN.The Group of Companies also increased its total contracted and verbally awarded (mainly contracts in process) projects to $80.4M CDN from $78.5M CDN of which approximately $40.0M CDN is currently scheduled to carry over into 2021/22.“While we are proceeding cautiously as an organization during these unprecedented times, with the health and safety of our...

Continue reading

Stitch Fix Announces Date for Third Quarter Fiscal 2020 Earnings Release and Conference Call

SAN FRANCISCO, May 19, 2020 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ:SFIX), the leading online personal styling service, today announced that it will release its financial results for its third quarter of fiscal year 2020 ended May 2, 2020 after market close on Monday, June 8, 2020 followed by a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss Stitch Fix’s financial results and outlook. The call will be hosted by Katrina Lake, founder and CEO, Mike Smith, President, COO, and interim CFO, and Elizabeth Spaulding, President. A live webcast will be accessible on the investor relations section of the Stitch Fix website at https://investors.stitchfix.com. The call can also be accessed domestically at (800) 263-0877 and internationally at (323) 794-2094, passcode 8685457.A telephonic replay will be available through Monday,...

Continue reading

EXL’s LifePRO® Platform Wins XCelent Customer Base Award

NEW YORK, May 19, 2020 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS] a leading operations management and analytics company, today announced its LifePRO® policy administration platform has received the XCelent Customer Base Award from research firm Celent.The award was announced as part of Celent’s Report “North American Policy Administration Systems 2019,” which ranked 20 policy administration systems in use or marketed for North American life, pension, and annuities products. EXL received the Customer Base award based on the number of insurers running any release of the system and the number of new insurance clients gained within the last two years.“EXL’s efforts over the last two years and the proposed roadmap demonstrate their commitment to modernizing a system that has been around for decades,” the report states. “LifePRO’s breadth...

Continue reading

University of Paris Researchers Utilize Fluidigm Mass Cytometry and Maxpar Direct Immune Profiling Assay to Identify Distinct Phenotype among Patients with Severe COVID-19

SOUTH SAN FRANCISCO, Calif., May 19, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that researchers at the University of Paris have utilized mass cytometry to identify profound changes in the immune systems of critically ill COVID-19 patients. The findings may help define a population of COVID-19 patients at high risk for becoming critically ill, and they suggest a possible benefit from anti-inflammatory therapies.The study, available online through medRxiv and pending peer review, utilized the Fluidigm® Maxpar® Direct™ Immune Profiling Assay™ and Maxpar Pathsetter™ analysis software. The assay offers a fixed panel of 30 standard markers of immune activity, to which the researchers added two...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.